These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6664936)

  • 1. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the role of catecholamines in the action of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):367-76. PubMed ID: 6664939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some pharmacological and biochemical effects of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Stasiak A; Maciejewski A; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):359-66. PubMed ID: 6664938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the effect of fibrinopeptides A and B on the central nervous system.
    Bernacka I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):407-14. PubMed ID: 7329866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examinations on contribution of bradykinin in the action of dopamine in circulatory system of rats. I. Influence of bradykinin in the action of dopamine on arterial blood pressure of rats.
    Fiedorowicz R; Moniuszko-Jakoniuk J; Wiśniewski K
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):739-48. PubMed ID: 6675575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro.
    Moore PK; Hussaini I; Bhardwaj R
    Eur J Pharmacol; 1988 Aug; 153(2-3):231-8. PubMed ID: 3053211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of antiinflammatory activity of fibrinogen and fibrinopeptides in rats.
    Ruhenstroth-Bauer G; Scherer R; Hornberger M; Tongendorff G
    Inflammation; 1981 Dec; 5(4):343-51. PubMed ID: 7327698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examinations on contribution of bradykinin in the action of dopamine in circulatory system of rats. II. Influence of bradykinin in the action of dopamine on the vessel perfusion of the isolated hindpaw of rats.
    Fiedorowicz R; Moniuszko-Jakoniuk J; Wiśniewski K
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):749-60. PubMed ID: 6326707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta 2 receptor plays a role in the hypotensive effect of L-dopa.
    Quevedo M; Prieto JC; Pérez-Olea J
    Acta Physiol Pharmacol Ther Latinoam; 1995; 45(1):19-25. PubMed ID: 8580515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vasodilatation produced by dopamine after adrenergic blockade.
    Schuelke DM; Mark AL; Schmid PG; Eckstein JW
    J Pharmacol Exp Ther; 1971 Feb; 176(2):320-7. PubMed ID: 4998690
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of fibrinopeptide B.
    Moore PK; Hussaini I; Bhardwaj R
    J Pharm Pharmacol; 1988 Aug; 40(8):558-61. PubMed ID: 2907010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.